The following represents disclosure information provided by authors of this abstract. The Breast Cancer Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Chemotherapy treatment patterns for early-stage breast cancer (ESBC): Decreasing use of anthracycline-based regimens.
Katherine M. Serrurier
No relevant relationships to disclose
Jimmy Hwang
No relevant relationships to disclose
Joseph P. McGuire
No relevant relationships to disclose
Ann C. Griffin
No relevant relationships to disclose
Michelle E. Melisko
No relevant relationships to disclose
Hope S. Rugo
Research Funding - Sanofi